首页 > 最新文献

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE最新文献

英文 中文
Renal Lipid Alterations From Diabetes to Early-Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin
IF 5.3 Pub Date : 2025-02-12 DOI: 10.1111/jcmm.70419
Zhijie Li, Hongmiao Wang, Nan Liu, Xiayuchen Lan, Ailing Xie, Ge Yuan, Bowen Li, Jiaxin Geng, Xiaodan Liu

Lipotoxicity plays a crucial role in the progression of diabetic kidney disease (DKD), yet the dynamic changes in renal lipid composition from diabetes to early-stage DKD remain unclear. Free fatty acids, lactosylceramides and cardiolipin (CL) were identified as the most significantly altered lipids by quantitatively comparing targeted lipids in the renal cortex of the classic spontaneous diabetic db/db mice using high-coverage targeted lipidomics. Further investigation into the causes and effects of decreased CL, which is a unique mitochondrial phospholipid, was conducted in mitochondria-rich renal proximal tubular cells by using western blotting, real-time PCR, immunohistochemistry and transmission electron microscopy. Reduced expression of cardiolipin synthase, a key enzyme in the CL synthesis pathway, and inhibition of CL-related mitophagy were confirmed under high glucose conditions. In addition, the protective effect of CL-targeted Szeto-Schiller 31 in preserving mitophagy was demonstrated in both in vivo and in vitro studies. These findings provide new insights into the pathogenesis of early-stage DKD from a lipid perspective and offer a theoretical basis for discovering new treatments.

{"title":"Renal Lipid Alterations From Diabetes to Early-Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin","authors":"Zhijie Li,&nbsp;Hongmiao Wang,&nbsp;Nan Liu,&nbsp;Xiayuchen Lan,&nbsp;Ailing Xie,&nbsp;Ge Yuan,&nbsp;Bowen Li,&nbsp;Jiaxin Geng,&nbsp;Xiaodan Liu","doi":"10.1111/jcmm.70419","DOIUrl":"https://doi.org/10.1111/jcmm.70419","url":null,"abstract":"<p>Lipotoxicity plays a crucial role in the progression of diabetic kidney disease (DKD), yet the dynamic changes in renal lipid composition from diabetes to early-stage DKD remain unclear. Free fatty acids, lactosylceramides and cardiolipin (CL) were identified as the most significantly altered lipids by quantitatively comparing targeted lipids in the renal cortex of the classic spontaneous diabetic <i>db/db</i> mice using high-coverage targeted lipidomics. Further investigation into the causes and effects of decreased CL, which is a unique mitochondrial phospholipid, was conducted in mitochondria-rich renal proximal tubular cells by using western blotting, real-time PCR, immunohistochemistry and transmission electron microscopy. Reduced expression of cardiolipin synthase, a key enzyme in the CL synthesis pathway, and inhibition of CL-related mitophagy were confirmed under high glucose conditions. In addition, the protective effect of CL-targeted Szeto-Schiller 31 in preserving mitophagy was demonstrated in both in vivo and in vitro studies. These findings provide new insights into the pathogenesis of early-stage DKD from a lipid perspective and offer a theoretical basis for discovering new treatments.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70419","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bu Yang Huan Wu Prevents Osteogenic Effect of Muscle-Derived Stromal Cells via Regulating JAK/STAT Pathway 补阳还五汤通过调节 JAK/STAT 通路防止肌肉来源基质细胞的成骨效应
IF 5.3 Pub Date : 2025-02-12 DOI: 10.1111/jcmm.70413
Guorui Cao, Shaoyun Zhang, Yuanping Liao, Chen Yue, Lanbo Yang, Jiayi Guo, Peijian Tong, Honglue Tan

Heterotopic ossification (HO) is a crucial pathological process in which bone or calcification develop in skeletal muscle and surrounding soft tissues. Muscle-derived stromal cells (MDSC) are important muscle-resident mesenchymal progenitor cells and macrophage-derived oncostatin M (OSM) can induce osteogenic differentiation. Bu Yang Huan Wu (BYHW), which has a long history of use in restraining inflammation, can prevent osteogenic differentiation and HO formation while underlying mechanism is still unclear. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway is an important pathway to regulate osteogenic differentiation of related cells. In this study, we investigated whether BYHW could inhibit osteogenesis effect of MDSC through OSM mediated by macrophages, and whether JAK/STAT pathway regulated this biological process. We found that activated macrophages promoted osteogenic differentiation of MDSC through OSM and BYHW could decrease the level of OSM and osteogenic activity of MDSC. Further, we confirmed the regulatory effect of JAK/STAT pathway, blocking this pathway could suppress the level of OSM and osteogenic differentiation of MDSC. We showed that BYHW could suppress osteogenic differentiation of MDSC through JAK/STAT signalling. These findings expand the application scope of traditional Chinese medicine and provide a basis for the further investigation of the potential therapeutic role of HO.

{"title":"Bu Yang Huan Wu Prevents Osteogenic Effect of Muscle-Derived Stromal Cells via Regulating JAK/STAT Pathway","authors":"Guorui Cao,&nbsp;Shaoyun Zhang,&nbsp;Yuanping Liao,&nbsp;Chen Yue,&nbsp;Lanbo Yang,&nbsp;Jiayi Guo,&nbsp;Peijian Tong,&nbsp;Honglue Tan","doi":"10.1111/jcmm.70413","DOIUrl":"https://doi.org/10.1111/jcmm.70413","url":null,"abstract":"<p>Heterotopic ossification (HO) is a crucial pathological process in which bone or calcification develop in skeletal muscle and surrounding soft tissues. Muscle-derived stromal cells (MDSC) are important muscle-resident mesenchymal progenitor cells and macrophage-derived oncostatin M (OSM) can induce osteogenic differentiation. Bu Yang Huan Wu (BYHW), which has a long history of use in restraining inflammation, can prevent osteogenic differentiation and HO formation while underlying mechanism is still unclear. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway is an important pathway to regulate osteogenic differentiation of related cells. In this study, we investigated whether BYHW could inhibit osteogenesis effect of MDSC through OSM mediated by macrophages, and whether JAK/STAT pathway regulated this biological process. We found that activated macrophages promoted osteogenic differentiation of MDSC through OSM and BYHW could decrease the level of OSM and osteogenic activity of MDSC. Further, we confirmed the regulatory effect of JAK/STAT pathway, blocking this pathway could suppress the level of OSM and osteogenic differentiation of MDSC. We showed that BYHW could suppress osteogenic differentiation of MDSC through JAK/STAT signalling. These findings expand the application scope of traditional Chinese medicine and provide a basis for the further investigation of the potential therapeutic role of HO.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70413","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in Research on Regulated Cell Death in Cerebral Ischaemic Injury After Cardiac Arrest
IF 5.3 Pub Date : 2025-02-12 DOI: 10.1111/jcmm.70404
Zumin Chen, Shuangwei Wang, Tian Shu, Senlin Xia, Yanmei He, Yanhan Yang

Ischaemic damage to the brain is the main cause of brain injury after cardiac arrest. The current treatment focuses on early reperfusion, but reperfusion tends to cause reperfusion injury, which is a significant problem. Cell death is an irreversible and normal end to cell life, playing key roles in maintaining the homeostasis and development of multicellular organisms. To date, cell death can be classified into two categories: accidental cell death (ACD) and regulated cell death (RCD). Cell death plays an indispensable role in cerebral ischaemia injury. An increasing number of scholars are exploring the mechanisms and sites of cell death during targeted inhibition of cerebral ischaemia to treat cerebral ischaemia injury. In addition to the established cell death pathways, namely, the apoptosis, pyroptosis and necroptosis pathways, ferroptosis and cuproptosis pathways have been discovered. This article reviews the cell death pathways involved in ischaemic brain injury, discusses the roles played by these death modalities, and suggests therapeutic directions for future targeting of cell death sites.

{"title":"Progress in Research on Regulated Cell Death in Cerebral Ischaemic Injury After Cardiac Arrest","authors":"Zumin Chen,&nbsp;Shuangwei Wang,&nbsp;Tian Shu,&nbsp;Senlin Xia,&nbsp;Yanmei He,&nbsp;Yanhan Yang","doi":"10.1111/jcmm.70404","DOIUrl":"https://doi.org/10.1111/jcmm.70404","url":null,"abstract":"<p>Ischaemic damage to the brain is the main cause of brain injury after cardiac arrest. The current treatment focuses on early reperfusion, but reperfusion tends to cause reperfusion injury, which is a significant problem. Cell death is an irreversible and normal end to cell life, playing key roles in maintaining the homeostasis and development of multicellular organisms. To date, cell death can be classified into two categories: accidental cell death (ACD) and regulated cell death (RCD). Cell death plays an indispensable role in cerebral ischaemia injury. An increasing number of scholars are exploring the mechanisms and sites of cell death during targeted inhibition of cerebral ischaemia to treat cerebral ischaemia injury. In addition to the established cell death pathways, namely, the apoptosis, pyroptosis and necroptosis pathways, ferroptosis and cuproptosis pathways have been discovered. This article reviews the cell death pathways involved in ischaemic brain injury, discusses the roles played by these death modalities, and suggests therapeutic directions for future targeting of cell death sites.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin-(1–9) Improves the Cardioprotective Effects of Del Nido Cardioplegia Against Ischemia/Reperfusion Injury
IF 5.3 Pub Date : 2025-02-12 DOI: 10.1111/jcmm.70412
Evelyn Mendoza-Torres, Gina Sanchez, Wendy Rosales, María Clara Ospino, Luis Antonio Díaz-Ariza, Yuliet Montoya, John Bustamante, Jaime A. Riquelme, Mario Chiong, Sergio Lavandero

Del Nido cardioplegia (DNC), a blood-and-crystalloid solution containing high and low concentrations of potassium and calcium, respectively, is used as a single-dose antegrade infusion to induce immediate cardiac arrest in the surgery of patients with cardiovascular diseases requiring extracorporeal circulation. Adding cardioprotective molecules may further reduce the damage-triggered ischemia/reperfusion (I/R) injury. Angiotensin-(1–9) (Ang-(1–9)) and angiotensin-(1–7) (Ang-(1–7)), members of the counter-regulatory renin-angiotensin system, have shown cardioprotective effects in cardiac hypertrophy and I/R models. This study aimed to evaluate the effects of Ang-(1–9) and Ang-(1–7), as adjuvants of the DNC, on cardioprotection and ventricular function in isolated rat hearts subjected to I/R and in cultured neonatal rat ventricular myocytes subjected to simulated I/R (sI/R). The addition of DNC and Ang-(1–9) and Ang-(1–7) decreased lactic dehydrogenase (LDH) release in cultured cardiomyocytes subjected to sI/R in comparison to those cardiomyocytes subjected to sI/R and incubated with DNC alone. Moreover, hearts treated with Ang-(1–9) during reperfusion after DNC + I/R exhibited fewer arrhythmias and required less time to reach left ventricular developed pressure stability. Overall, reperfusion with DNC and Ang-(1–9) improves the recovery of the left ventricular function of the heart.

{"title":"Angiotensin-(1–9) Improves the Cardioprotective Effects of Del Nido Cardioplegia Against Ischemia/Reperfusion Injury","authors":"Evelyn Mendoza-Torres,&nbsp;Gina Sanchez,&nbsp;Wendy Rosales,&nbsp;María Clara Ospino,&nbsp;Luis Antonio Díaz-Ariza,&nbsp;Yuliet Montoya,&nbsp;John Bustamante,&nbsp;Jaime A. Riquelme,&nbsp;Mario Chiong,&nbsp;Sergio Lavandero","doi":"10.1111/jcmm.70412","DOIUrl":"https://doi.org/10.1111/jcmm.70412","url":null,"abstract":"<p>Del Nido cardioplegia (DNC), a blood-and-crystalloid solution containing high and low concentrations of potassium and calcium, respectively, is used as a single-dose antegrade infusion to induce immediate cardiac arrest in the surgery of patients with cardiovascular diseases requiring extracorporeal circulation. Adding cardioprotective molecules may further reduce the damage-triggered ischemia/reperfusion (I/R) injury. Angiotensin-(1–9) (Ang-(1–9)) and angiotensin-(1–7) (Ang-(1–7)), members of the counter-regulatory renin-angiotensin system, have shown cardioprotective effects in cardiac hypertrophy and I/R models. This study aimed to evaluate the effects of Ang-(1–9) and Ang-(1–7), as adjuvants of the DNC, on cardioprotection and ventricular function in isolated rat hearts subjected to I/R and in cultured neonatal rat ventricular myocytes subjected to simulated I/R (sI/R). The addition of DNC and Ang-(1–9) and Ang-(1–7) decreased lactic dehydrogenase (LDH) release in cultured cardiomyocytes subjected to sI/R in comparison to those cardiomyocytes subjected to sI/R and incubated with DNC alone. Moreover, hearts treated with Ang-(1–9) during reperfusion after DNC + I/R exhibited fewer arrhythmias and required less time to reach left ventricular developed pressure stability. Overall, reperfusion with DNC and Ang-(1–9) improves the recovery of the left ventricular function of the heart.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70412","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to ‘ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression’
IF 5.3 Pub Date : 2025-02-11 DOI: 10.1111/jcmm.70191

Baldi S, Zhang Q, Zhang Z, et al. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression. J Cell Mol Med. 2022;26:5984-5997. doi:10.1111/jcmm.17590.

In Salem Baldi et al., the VIM image of HCT116 cells in Figure 5B overlapped the VIM in Figure 5A due to technical error during image preparation. The correct figure is shown below. The authors confirm all results and conclusions of this article remain unchanged.

{"title":"Correction to ‘ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression’","authors":"","doi":"10.1111/jcmm.70191","DOIUrl":"https://doi.org/10.1111/jcmm.70191","url":null,"abstract":"<p>Baldi S, Zhang Q, Zhang Z, et al. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression. <i>J Cell Mol Med.</i> 2022;26:5984-5997. doi:10.1111/jcmm.17590.</p><p>In Salem Baldi et al., the VIM image of HCT116 cells in Figure 5B overlapped the VIM in Figure 5A due to technical error during image preparation. The correct figure is shown below. The authors confirm all results and conclusions of this article remain unchanged.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70191","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Axis of Gut Microbiota-Inflammatory Cytokine-Atrial Fibrillation in the Pathogenesis of Atrial Fibrillation
IF 5.3 Pub Date : 2025-02-10 DOI: 10.1111/jcmm.70379
Jun Chen, Yucheng Wang, Kangnan Wang, Ziwei Mei, Lihong Wang

A relationship may exist between the gut microbiota, inflammatory factors and atrial fibrillation (AF); however, the precise biological mechanisms linking these components remain uncertain.In this study, 211 single-nucleotide polymorphisms associated with the gut microbiota were collected from the MiBioGen consortium. Summary data for AF were sourced from large-scale genome-wide association studies. Two-step Mendelian randomization (MR) was applied to estimate the possible mediating effect of inflammatory cytokines on the causality between the gut microbiota and AF. MR confirmed the effects of class Lentisphaeria, family Bifidobacteriaceae, family XIII, genus Anaerostipes, genus Howardella, genus Intestinibacter, genus Lachnospiraceae (NK4A136 group), genus Odoribacter, genus Ruminococcus gnavus, order Bifidobacteriales, order Victivallales and phylum Lentisphaerae on AF prevention. Moreover, MR revealed the role of Fms-related tyrosine kinase 3 ligand, interleukin-6, interleukin-7, leukaemia inhibitory factor receptor, sulfotransferase 1A1 and tumour necrosis factor ligand superfamily member 12 in protecting against AF. Fibroblast growth factor 5, interleukin-2 receptor subunit β, and tumour necrosis factor had a causal effect, increasing AF risk. The mediation exploration indicated that the indirect effect of genus Lachnospiraceae (FCS020 group) (id: 11314) on AF mediated by interleukin-18 was OR 1.015 (95% confidence interval 1.000–1.037; mediation proportion = 9.494%). This study supplies genetic insights into the potential causal association between the gut microbiota and AF. These causal associations and mediating effects are useful for managing AF through manipulation of the gut microbiota.

{"title":"Exploring the Axis of Gut Microbiota-Inflammatory Cytokine-Atrial Fibrillation in the Pathogenesis of Atrial Fibrillation","authors":"Jun Chen,&nbsp;Yucheng Wang,&nbsp;Kangnan Wang,&nbsp;Ziwei Mei,&nbsp;Lihong Wang","doi":"10.1111/jcmm.70379","DOIUrl":"https://doi.org/10.1111/jcmm.70379","url":null,"abstract":"<p>A relationship may exist between the gut microbiota, inflammatory factors and atrial fibrillation (AF); however, the precise biological mechanisms linking these components remain uncertain.In this study, 211 single-nucleotide polymorphisms associated with the gut microbiota were collected from the MiBioGen consortium. Summary data for AF were sourced from large-scale genome-wide association studies. Two-step Mendelian randomization (MR) was applied to estimate the possible mediating effect of inflammatory cytokines on the causality between the gut microbiota and AF. MR confirmed the effects of class Lentisphaeria, family Bifidobacteriaceae, family XIII, genus <i>Anaerostipes</i>, genus <i>Howardella</i>, genus <i>Intestinibacter</i>, genus <i>Lachnospiraceae</i> (NK4A136 group), genus <i>Odoribacter</i>, genus <i>Ruminococcus gnavus</i>, order Bifidobacteriales, order Victivallales and phylum Lentisphaerae on AF prevention. Moreover, MR revealed the role of Fms-related tyrosine kinase 3 ligand, interleukin-6, interleukin-7, leukaemia inhibitory factor receptor, sulfotransferase 1A1 and tumour necrosis factor ligand superfamily member 12 in protecting against AF. Fibroblast growth factor 5, interleukin-2 receptor subunit β, and tumour necrosis factor had a causal effect, increasing AF risk. The mediation exploration indicated that the indirect effect of genus <i>Lachnospiraceae</i> (FCS020 group) (id: 11314) on AF mediated by interleukin-18 was OR 1.015 (95% confidence interval 1.000–1.037; mediation proportion = 9.494%). This study supplies genetic insights into the potential causal association between the gut microbiota and AF. These causal associations and mediating effects are useful for managing AF through manipulation of the gut microbiota.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70379","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights
IF 5.3 Pub Date : 2025-02-10 DOI: 10.1111/jcmm.70357
Chanon Piamsiri, Chayodom Maneechote, Siriporn C. Chattipakorn, Nipon Chattipakorn

Ischaemic heart disease (IHD) remains a leading cause of global morbidity and mortality. One significant contributor to the pathology of IHD is the excessive release of inflammatory mediators during the disease progression. Pyroptosis is a form of programmed cell death (PCD) triggered by the activation of inflammasomes and caspase 1. The activation of inflammatory caspase 1 proteolytically cleaves gasdermin D (GSDMD) to the activated form amino acid terminus (GSDMD-NT), leading to disruption of the plasma membrane. This cascade of events is considered the canonical pathway of pyroptosis. IHD also caused oxidative stress, thereby triggering noncanonical pyroptosis via the activation of caspases 4/5/11. Previous studies have provided compelling evidence of the close relationship between pyroptosis and the aetiology of IHD (e.g., acute myocardial infarction, myocardial ischaemia and reperfusion injury and chronic myocardial infarction), as well as the association of pyroptosis with unfavourable clinical outcomes. Several interventions aimed at targeting pyroptosis have demonstrated promising therapeutic benefits against IHD-related pathologies. This review provides mechanistic insights into the roles of pyroptosis in IHD from in vitro, in vivo and clinical perspectives. In-depth understanding into this area could also pave the way for the future development of novel therapeutic strategies targeting pyroptosis in IHD.

{"title":"Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights","authors":"Chanon Piamsiri,&nbsp;Chayodom Maneechote,&nbsp;Siriporn C. Chattipakorn,&nbsp;Nipon Chattipakorn","doi":"10.1111/jcmm.70357","DOIUrl":"https://doi.org/10.1111/jcmm.70357","url":null,"abstract":"<p>Ischaemic heart disease (IHD) remains a leading cause of global morbidity and mortality. One significant contributor to the pathology of IHD is the excessive release of inflammatory mediators during the disease progression. Pyroptosis is a form of programmed cell death (PCD) triggered by the activation of inflammasomes and caspase 1. The activation of inflammatory caspase 1 proteolytically cleaves gasdermin D (GSDMD) to the activated form amino acid terminus (GSDMD-NT), leading to disruption of the plasma membrane. This cascade of events is considered the canonical pathway of pyroptosis. IHD also caused oxidative stress, thereby triggering noncanonical pyroptosis via the activation of caspases 4/5/11. Previous studies have provided compelling evidence of the close relationship between pyroptosis and the aetiology of IHD (e.g., acute myocardial infarction, myocardial ischaemia and reperfusion injury and chronic myocardial infarction), as well as the association of pyroptosis with unfavourable clinical outcomes. Several interventions aimed at targeting pyroptosis have demonstrated promising therapeutic benefits against IHD-related pathologies. This review provides mechanistic insights into the roles of pyroptosis in IHD from in vitro, in vivo and clinical perspectives. In-depth understanding into this area could also pave the way for the future development of novel therapeutic strategies targeting pyroptosis in IHD.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70357","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Cell RNA-Seq Identifies Cell Subpopulations Contributing to Idiopathic Pulmonary Fibrosis in Humans
IF 5.3 Pub Date : 2025-02-10 DOI: 10.1111/jcmm.70402
Tangjuan Zhang, Zhichao Hou, Zheng Ding, Peng Wang, Xue Pan, Xiangnan Li

The cell populations, particularly subpopulations, involved in the onset and progression of idiopathic pulmonary fibrosis (IPF) remain incompletely understood. This study employed single-cell RNA-seq to identify cell populations and subpopulations with significantly altered proportions in the lungs of patients with IPF. In IPF lungs, endothelial cell proportions were significantly increased, while alveolar epithelial cell proportions were markedly decreased. Among the three identified fibroblast subpopulations, the proportion of myofibroblasts was significantly increased, while the proportions of the other two fibroblast subtypes were reduced. Similarly, within the three macrophage subpopulations, the macrophage_SPP1 subpopulation, localised to fibroblastic foci, showed a significant increase in proportion, while the alveolar macrophage subpopulation was significantly reduced. Trajectory analysis revealed that fibroblasts in IPF lungs could differentiate into myofibroblasts, and alveolar macrophages could transition into the macrophage_SPP1 subpopulation. Among T-cell subpopulations, only the CD4 T_FOXP3 subpopulation exhibited a significant change, whereas all four B-cell subpopulations showed significant proportional shifts. These findings provide a comprehensive view of the cellular alterations contributing to IPF pathogenesis. Extensive interactions among various cell populations and subpopulations were identified. The proportions of various cell populations and subpopulations in IPF lungs, including endothelial cells, fibroblasts, macrophages and B cells, were significantly altered. Further in-depth investigation into the roles of cell subpopulations with significantly altered proportions in the onset and progression of IPF will provide valuable insights into the pathological mechanisms underlying the disease. This understanding could facilitate the development of novel therapeutic strategies and medications for IPF treatment.

{"title":"Single Cell RNA-Seq Identifies Cell Subpopulations Contributing to Idiopathic Pulmonary Fibrosis in Humans","authors":"Tangjuan Zhang,&nbsp;Zhichao Hou,&nbsp;Zheng Ding,&nbsp;Peng Wang,&nbsp;Xue Pan,&nbsp;Xiangnan Li","doi":"10.1111/jcmm.70402","DOIUrl":"https://doi.org/10.1111/jcmm.70402","url":null,"abstract":"<p>The cell populations, particularly subpopulations, involved in the onset and progression of idiopathic pulmonary fibrosis (IPF) remain incompletely understood. This study employed single-cell RNA-seq to identify cell populations and subpopulations with significantly altered proportions in the lungs of patients with IPF. In IPF lungs, endothelial cell proportions were significantly increased, while alveolar epithelial cell proportions were markedly decreased. Among the three identified fibroblast subpopulations, the proportion of myofibroblasts was significantly increased, while the proportions of the other two fibroblast subtypes were reduced. Similarly, within the three macrophage subpopulations, the macrophage_SPP1 subpopulation, localised to fibroblastic foci, showed a significant increase in proportion, while the alveolar macrophage subpopulation was significantly reduced. Trajectory analysis revealed that fibroblasts in IPF lungs could differentiate into myofibroblasts, and alveolar macrophages could transition into the macrophage_SPP1 subpopulation. Among T-cell subpopulations, only the CD4 T_FOXP3 subpopulation exhibited a significant change, whereas all four B-cell subpopulations showed significant proportional shifts. These findings provide a comprehensive view of the cellular alterations contributing to IPF pathogenesis. Extensive interactions among various cell populations and subpopulations were identified. The proportions of various cell populations and subpopulations in IPF lungs, including endothelial cells, fibroblasts, macrophages and B cells, were significantly altered. Further in-depth investigation into the roles of cell subpopulations with significantly altered proportions in the onset and progression of IPF will provide valuable insights into the pathological mechanisms underlying the disease. This understanding could facilitate the development of novel therapeutic strategies and medications for IPF treatment.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70402","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs
IF 5.3 Pub Date : 2025-02-10 DOI: 10.1111/jcmm.70361
Lea Eckhart, Sabrina Rau, Markus Eckstein, Phillip R. Stahl, Hiresh Ayoubian, Julia Heinzelbecker, Farzaneh Zohari, Arndt Hartmann, Michael Stöckle, Hans-Peter Lenhof, Kerstin Junker

The aim of this study was to validate the diagnostic potential of four previously identified miRNAs in two independent cohorts and to develop accurate classification models to predict invasiveness of bladder cancer. Furthermore, molecular subtypes were investigated. The miRNAs were isolated from pTa low-grade (lg) (n = 113), pT1 high-grade (hg) (n = 133) and muscle-invasive bladder cancer (MIBC) (n = 136) tumour tissue samples (FFPE) after either transurethral resection of a bladder tumour (TURB) or cystectomy (CYS). In both cohorts, the expression of miR-138-5p and miR-200a-3p was significantly lower, and the expression of miR-146b-5p and miR-155-5p was significantly higher in MIBC compared to pTa lg. A k-nearest neighbours (KNN) classifier trained to distinguish pTa lg from MIBC based on three miRNAs achieved an accuracy of 0.94. The accuracy remained at 0.91 when the classifier was applied exclusively to the TURB samples. To guarantee reliable predictions, a conformal prediction approach was applied to the KNN model, which eliminated all misclassifications on the test cohort. pT1 hg samples were classified as MIBC in 32% of cases using the KNN model. miR-146b-5p, miR-155-5p and miR-200a-3p expressions are significantly associated with particular molecular subtypes. In conclusion, we confirmed that the four miRNAs significantly distinguish MIBC from NMIBC. A classification model based on three miRNAs was able to accurately classify the phenotype of invasive tumors. This could potentially support the histopathological diagnosis in bladder cancer and therefore, the clinical decision between performing a radical cystectomy and pursuing bladder-conserving strategies, especially in pT1 hg tumors.

{"title":"Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs","authors":"Lea Eckhart,&nbsp;Sabrina Rau,&nbsp;Markus Eckstein,&nbsp;Phillip R. Stahl,&nbsp;Hiresh Ayoubian,&nbsp;Julia Heinzelbecker,&nbsp;Farzaneh Zohari,&nbsp;Arndt Hartmann,&nbsp;Michael Stöckle,&nbsp;Hans-Peter Lenhof,&nbsp;Kerstin Junker","doi":"10.1111/jcmm.70361","DOIUrl":"https://doi.org/10.1111/jcmm.70361","url":null,"abstract":"<p>The aim of this study was to validate the diagnostic potential of four previously identified miRNAs in two independent cohorts and to develop accurate classification models to predict invasiveness of bladder cancer. Furthermore, molecular subtypes were investigated. The miRNAs were isolated from pTa low-grade (lg) (<i>n</i> = 113), pT1 high-grade (hg) (<i>n</i> = 133) and muscle-invasive bladder cancer (MIBC) (<i>n</i> = 136) tumour tissue samples (FFPE) after either transurethral resection of a bladder tumour (TURB) or cystectomy (CYS). In both cohorts, the expression of miR-138-5p and miR-200a-3p was significantly lower, and the expression of miR-146b-5p and miR-155-5p was significantly higher in MIBC compared to pTa lg. A k-nearest neighbours (KNN) classifier trained to distinguish pTa lg from MIBC based on three miRNAs achieved an accuracy of 0.94. The accuracy remained at 0.91 when the classifier was applied exclusively to the TURB samples. To guarantee reliable predictions, a <i>conformal prediction</i> approach was applied to the KNN model, which eliminated all misclassifications on the test cohort. pT1 hg samples were classified as MIBC in 32% of cases using the KNN model. miR-146b-5p, miR-155-5p and miR-200a-3p expressions are significantly associated with particular molecular subtypes. In conclusion, we confirmed that the four miRNAs significantly distinguish MIBC from NMIBC. A classification model based on three miRNAs was able to accurately classify the phenotype of invasive tumors. This could potentially support the histopathological diagnosis in bladder cancer and therefore, the clinical decision between performing a radical cystectomy and pursuing bladder-conserving strategies, especially in pT1 hg tumors.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70361","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the Epigenetic Landscape for Lung Cancer Treatment
IF 5.3 Pub Date : 2025-02-10 DOI: 10.1111/jcmm.70425
Kostas A. Papavassiliou, Amalia A. Sofianidi, Antonios N. Gargalionis, Athanasios G. Papavassiliou
<p>The term ‘epigenetics’ was introduced in 1942 by embryologist Conrad Waddington [<span>1</span>]. However, it was not until the early 21st century that the concept began to attract widespread attention. The field reached a pivotal moment in 2022 when Douglas Hanahan identified epigenetic alterations as a fundamental hallmark of cancer, emphasising their critical contribution to tumour development and progression [<span>2</span>]. Notably, lung cancer is characterised by both intra- and intertumoral heterogeneity, driven by genetic changes alongside epigenetic modifications [<span>3</span>]. Due to the extensive and multifaceted role of epigenetic regulation in lung cancer, targeting the reversible nature of the epigenome presents a promising therapeutic approach to address the complexity of tumour heterogeneity, which has long posed serious challenges in lung cancer treatment. Herein, we highlight recent advances in epigenome-targeting strategies in the highly demanding field of lung cancer therapeutics.</p><p>The antitumor potential of histone deacetylase (HDAC) inhibitors has been well recognised for almost 20 years [<span>4</span>]. Suberoylanilide hydroxamic acid (SAHA; commonly known as vorinostat) is a leading pan-HDAC inhibitor of class I/II HDAC enzymes (HDAC1/2) with a demonstrated favourable safety profile in a phase I clinical trial involving patients with <i>Bcl-2-like protein 11</i> (<i>BIM</i>) deletion-containing non-small cell lung cancer (NSCLC) resistant to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy [<span>5</span>]. Hydroxamic acid-derived HDAC inhibitors, such as trichostatin A (TSA) and quinostat, have shown promising preclinical efficacy against NSCLC [<span>6</span>]. These compounds induce alterations in tight junction proteins of human lung adenocarcinoma cells while preserving the integrity of the normal epithelial barrier in healthy cells [<span>6</span>].</p><p>Other compelling targets within the epigenome of lung cancer are DNA methyltransferases (DNMTs). In a phase I study, the DNMT inhibitor azacitidine (5-azacytidine) demonstrated a reduction in global DNA methylation of the bronchial epithelium following aerosolised treatment in NSCLC patients [<span>7</span>]. The treatment was associated with negligible plasma concentrations of the DNMT inhibitor, which indicate minimal systemic absorption of the drug, and thus, exhibited excellent tolerability [<span>7</span>]. Another DNMT inhibitor, decitabine (a deoxycycline and cytarabine nucleotide derivative), was recently found to preclinically abate NSCLC cell growth and metastatic potential when co-administered with aspirin by inhibiting the β-catenin/signal transducer and activator of transcription 3 (STAT3) signalling axis [<span>8</span>]. An additional drug influenced by DNMTs is temozolomide, an oral alkylating agent that interferes with DNA through the ability of its metabolites to deposit methyl groups on DNA guanine bases
{"title":"Targeting the Epigenetic Landscape for Lung Cancer Treatment","authors":"Kostas A. Papavassiliou,&nbsp;Amalia A. Sofianidi,&nbsp;Antonios N. Gargalionis,&nbsp;Athanasios G. Papavassiliou","doi":"10.1111/jcmm.70425","DOIUrl":"https://doi.org/10.1111/jcmm.70425","url":null,"abstract":"&lt;p&gt;The term ‘epigenetics’ was introduced in 1942 by embryologist Conrad Waddington [&lt;span&gt;1&lt;/span&gt;]. However, it was not until the early 21st century that the concept began to attract widespread attention. The field reached a pivotal moment in 2022 when Douglas Hanahan identified epigenetic alterations as a fundamental hallmark of cancer, emphasising their critical contribution to tumour development and progression [&lt;span&gt;2&lt;/span&gt;]. Notably, lung cancer is characterised by both intra- and intertumoral heterogeneity, driven by genetic changes alongside epigenetic modifications [&lt;span&gt;3&lt;/span&gt;]. Due to the extensive and multifaceted role of epigenetic regulation in lung cancer, targeting the reversible nature of the epigenome presents a promising therapeutic approach to address the complexity of tumour heterogeneity, which has long posed serious challenges in lung cancer treatment. Herein, we highlight recent advances in epigenome-targeting strategies in the highly demanding field of lung cancer therapeutics.&lt;/p&gt;&lt;p&gt;The antitumor potential of histone deacetylase (HDAC) inhibitors has been well recognised for almost 20 years [&lt;span&gt;4&lt;/span&gt;]. Suberoylanilide hydroxamic acid (SAHA; commonly known as vorinostat) is a leading pan-HDAC inhibitor of class I/II HDAC enzymes (HDAC1/2) with a demonstrated favourable safety profile in a phase I clinical trial involving patients with &lt;i&gt;Bcl-2-like protein 11&lt;/i&gt; (&lt;i&gt;BIM&lt;/i&gt;) deletion-containing non-small cell lung cancer (NSCLC) resistant to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy [&lt;span&gt;5&lt;/span&gt;]. Hydroxamic acid-derived HDAC inhibitors, such as trichostatin A (TSA) and quinostat, have shown promising preclinical efficacy against NSCLC [&lt;span&gt;6&lt;/span&gt;]. These compounds induce alterations in tight junction proteins of human lung adenocarcinoma cells while preserving the integrity of the normal epithelial barrier in healthy cells [&lt;span&gt;6&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;Other compelling targets within the epigenome of lung cancer are DNA methyltransferases (DNMTs). In a phase I study, the DNMT inhibitor azacitidine (5-azacytidine) demonstrated a reduction in global DNA methylation of the bronchial epithelium following aerosolised treatment in NSCLC patients [&lt;span&gt;7&lt;/span&gt;]. The treatment was associated with negligible plasma concentrations of the DNMT inhibitor, which indicate minimal systemic absorption of the drug, and thus, exhibited excellent tolerability [&lt;span&gt;7&lt;/span&gt;]. Another DNMT inhibitor, decitabine (a deoxycycline and cytarabine nucleotide derivative), was recently found to preclinically abate NSCLC cell growth and metastatic potential when co-administered with aspirin by inhibiting the β-catenin/signal transducer and activator of transcription 3 (STAT3) signalling axis [&lt;span&gt;8&lt;/span&gt;]. An additional drug influenced by DNMTs is temozolomide, an oral alkylating agent that interferes with DNA through the ability of its metabolites to deposit methyl groups on DNA guanine bases","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70425","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1